New York Medical Cannabis Industry Association
New York Medical Cannabis Industry Association is a nonprofit trade association representing nine of the ten Registered Organizations in New York's medical cannabis program, advocating to state legislators and regulators on patient access, affordability, and adult-use policy implementation.
- Company typePrivate
- Founded2014
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What New York Medical Cannabis Industry Association does
The New York Medical Cannabis Industry Association (NYMCIA) is a nonprofit trade association founded following New York's 2014 Compassionate Care Act to represent medical cannabis operators in the state. It represents nine of the ten Registered Organizations licensed under New York's medical cannabis program, including major multi-state operators such as The Cannabist Company, Cresco Labs, Curaleaf, Green Thumb Industries, iAnthus, Canopy USA, and Pharmacann, whose members have collectively invested over $250 million in medical cannabis infrastructure in the state.
NYMCIA's core function is policy advocacy and industry representation. The association lobbies state legislators, regulators (the Office of Cannabis Management and Cannabis Control Board), and other policymakers on issues including patient access, affordability, dispensary expansion, social equity in licensing, and the protection of the medical program from adverse effects of adult-use legalization. It played a key role in securing passage of the 2021 Marijuana Regulation and Taxation Act (MRTA) and continues to drive a formal 2025 Legislative Agenda. Operational support includes a public website (protectnymedmar.com), a monthly newsletter, a members-only portal, direct legislative testimony, and contracted government-relations support through Marathon Strategies.
The association is governed by an executive board staffed by senior executives from its largest member companies, with Ngiste Abebe (Columbia Care) serving as President, Don Williams (Curaleaf) as Chair, Kellie Rivera (The Cannabist Company) as Vice Chair, and Rebecca Brown (GTI) as Secretary. NYMCIA appears operationally aligned with the National Cannabis Industry Association (NCIA), whose Terms & Conditions govern the NYMCIA website. The organization is small (1-10 employees) and does not develop or sell products, services, or technology.
New York Medical Cannabis Industry Association firmographics
Firmographics- Name
- New York Medical Cannabis Industry Association
- Legal name
- National Cannabis Industry Association
- Website
- https://protectnymedmar.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- New York Medical Cannabis Industry Association is a nonprofit trade association representing nine of the ten Registered Organizations in New York's medical cannabis program, advocating to state legislators and regulators on patient access, affordability, and adult-use policy implementation.
- Ownership category
- akta.pro rank
New York Medical Cannabis Industry Association industry classification
Industry- Product category
- Cannabis Industry Trade Association Services
- NAICS
- Business Associations (813910)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Cannabis Dispensary Chains & Multi-Location Operators (MSO/Regional) (CRANAFAD)
- akta.pro secondary industry
- Medical Cannabis Dispensaries (CRANAFAB)
Keywords
Where New York Medical Cannabis Industry Association is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
New York Medical Cannabis Industry Association business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations
Distribution channels1 record
Marketing channels4 records
New York Medical Cannabis Industry Association product offering
Product offeringCore offering
NYMCIA is a nonprofit trade association that represents the Registered Organizations operating New York's medical cannabis program and advocates for policies that preserve and expand patient access to medical cannabis. Its activities include legislative advocacy, regulatory engagement, public-comment filings, media communications, and member coordination on policy positions, while its members (Columbia Care/The Cannabist Company, Cresco Labs, Curaleaf, Green Thumb Industries, iAnthus, Canopy USA, and Pharmacann) collectively invest in the state's medical cannabis infrastructure.
Product overview
The New York Medical Cannabis Industry Association (NYMCIA) is a trade association that does not offer its own distinct products or services. The association's members (The Cannabist Company, Cresco Labs, Curaleaf, Green Thumb Industries, iAnthus, Canopy USA, and Pharmacann) provide medical cannabis products including flower, edibles, oils, tablets, and topical formulations through licensed dispensaries in New York State. NYMCIA's activities are focused on advocacy, policy development, and supporting patient access to medical cannabis rather than product development or technology offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Member advocacy and industry representation services
Companies that use New York Medical Cannabis Industry Association
Customer profileSegments3 records
Ideal customer profiles2 records
New York Medical Cannabis Industry Association technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
New York Medical Cannabis Industry Association partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights4 records
New York Medical Cannabis Industry Association competitors and assessment
Company assessmentRegional players
- Colorado Cannabis Chamber of Commerce: A Colorado-based trade association representing cannabis operators in one of the longest-standing legal markets. Structurally comparable as an operator-funded state advocacy body, though serving a mature adult-use market rather than the medical-program-in-crisis context NYMCIA operates in.
- California Cannabis Industry Association: A state-level trade association representing licensed cannabis operators in California, structurally analogous to NYMCIA in its operator-representation, legislative-advocacy, and regulatory-engagement remit, but operating in California rather than New York.
- Cannabis Control Commission of Massachusetts industry stakeholders / Massachusetts Cannabis Association: A Massachusetts-based industry trade group representing licensed cannabis operators in that state's adult-use and medical programs. Direct functional analog to NYMCIA at the state level — dues-funded operator advocacy, regulatory engagement, and legislative testimony.
- New Jersey Cannabis Trade Association: A trade association representing licensed cannabis operators in New Jersey, operating in an adjacent Northeast regulatory market. Comparable to NYMCIA in advocacy-only, operator-funded model serving a state medical-and-adult-use program.
Direct peers
- Marijuana Policy Project (MPP): A leading U.S. cannabis policy advocacy organization that has driven state-level legalization campaigns. Comparable to NYMCIA in policy advocacy focus, particularly on legislation like NY's MRTA, though MPP works nationally rather than as a single-state operator association.
- National Cannabis Industry Association (NCIA): NCIA is the largest U.S. cannabis trade association, referenced directly in NYMCIA's Terms & Conditions as the data controller. It is the national umbrella organization most directly comparable to NYMCIA's role as a state-level trade body, with overlapping member MSOs (Curaleaf, GTI, Cresco, Canopy).
- Cannabis Trade Federation: A national cannabis trade and lobbying organization focused on federal policy and state coordination, structurally similar to NYMCIA as a trade body representing licensed cannabis operators. Provides a peer reference for advocacy-led, dues-funded trade association models.
- NORML: Long-standing U.S. cannabis policy reform organization focused on legalization, decriminalization, and patient access. Comparable to NYMCIA in mission (advocacy for medical/adult-use cannabis reform) though operating nationally and via grassroots rather than operator dues.
Emerging players
- Americans for Safe Access: A national advocacy organization focused specifically on medical cannabis patient access and therapeutic use. Comparable to NYMCIA's core medical-patient-access mission, though smaller and patient-led rather than operator-led.
- Patients Out of Time: A nonprofit focused on medical cannabis patient access and clinical research, including continuing medical education for healthcare providers. Overlaps with NYMCIA's medical-patient mission and practitioner-education advocacy angle.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
New York Medical Cannabis Industry Association social profiles
Digital presenceNew York Medical Cannabis Industry Association financial estimates
Financial estimateRevenue estimate
Valuation estimate
New York Medical Cannabis Industry Association leadership team
Management profileNumber of profiles
Profiles6 records
New York Medical Cannabis Industry Association funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
New York Medical Cannabis Industry Association M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about New York Medical Cannabis Industry Association
What does New York Medical Cannabis Industry Association do?
NYMCIA is a nonprofit trade association that represents the Registered Organizations operating New York's medical cannabis program and advocates for policies that preserve and expand patient access to medical cannabis. Its activities include legislative advocacy, regulatory engagement, public-comment filings, media communications, and member coordination on policy positions, while its members (Columbia Care/The Cannabist Company, Cresco Labs, Curaleaf, Green Thumb Industries, iAnthus, Canopy USA, and Pharmacann) collectively invest in the state's medical cannabis infrastructure.
Is New York Medical Cannabis Industry Association a public or private company?
New York Medical Cannabis Industry Association is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was New York Medical Cannabis Industry Association founded?
New York Medical Cannabis Industry Association was founded in 2014. It employs 1 to 10 people.
Where is New York Medical Cannabis Industry Association based?
New York Medical Cannabis Industry Association is headquartered in New York, United States, in the North America region.
Who are New York Medical Cannabis Industry Association's main competitors?
Regional players on record are Colorado Cannabis Chamber of Commerce, California Cannabis Industry Association, Cannabis Control Commission of Massachusetts industry stakeholders / Massachusetts Cannabis Association and New Jersey Cannabis Trade Association. Direct peers are Marijuana Policy Project (MPP), National Cannabis Industry Association (NCIA), Cannabis Trade Federation and NORML. Emerging players are Americans for Safe Access and Patients Out of Time.
Does New York Medical Cannabis Industry Association have an API?
No public API is recorded for New York Medical Cannabis Industry Association.
What industry is New York Medical Cannabis Industry Association in?
New York Medical Cannabis Industry Association's product category is Cannabis Industry Trade Association Services. Its primary akta.pro industry code is CRANAFAD, Cannabis Dispensary Chains & Multi-Location Operators (MSO/Regional), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 813910 and its SIC code is 8600.